Omnicuris Logo
HyugaLife Secures Rs 100 Crore to Revolutionize Wellness

HyugaLife Secures Rs 100 Crore to Revolutionize Wellness

Read More
Full Text
Today
Health and wellness platform HyugaLife recently secured Rs 100 crore in Series A funding. Consequently, this significant investment highlights the growing demand for **supplement market authenticity** across India. Led by IvyCap Ventures, the round also included participation from First Bridge Fund. Furthermore, the company intends to use these funds to improve AI-powered personalization and expand its retail footprint.

HyugaLife operates as a direct-to-consumer marketplace for proteins, supplements, and health foods. It specifically aims to solve the \"trust problem\" that currently plagues the health sector. Additionally, the platform sources directly from brands to eliminate the risks associated with third-party sellers. Therefore, consumers receive genuine products verified through independent laboratory testing for nutrition and heavy metals.

Improving Supplement Market Authenticity with Technology



The startup plans to strengthen its AI capabilities to offer highly personalized recommendations. Moreover, it will expand its dark store network to ensure faster delivery times for customers. Establishing an offline presence remains a key priority for the brand in the coming year. This hybrid approach will help bridge the gap between online convenience and physical trust.

Indian cricketer KL Rahul serves as a key investor in the platform. Currently, HyugaLife lists over 10,000 products from more than 450 verified brands. CEO Sachin Parikh emphasized that doubling down on authenticity guarantees remains their core mission. Specifically, through expanded lab-tested offerings, the brand seeks to set a new standard in the wellness industry.

Frequently Asked Questions


Q1: What is HyugaLife's primary focus with the new funding?


HyugaLife plans to use the Rs 100 crore to enhance AI-driven personalization, expand its dark store network for faster deliveries, and establish an offline retail presence.


Q2: How does the platform ensure the quality of its supplements?


The platform sources products directly from brands to eliminate third-party sellers. Additionally, it conducts independent lab tests for nutrition and heavy metals to ensure safety and quality.



Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.


References



  1. HyugaLife raises Rs 100 crore in Series A funding round - ETHealthworld

  2. IvyCap Ventures Portfolio Analysis 2026

  3. Direct-to-Consumer Trends in Indian Health E-commerce

"
Login to continue

More from MedShots Daily

HyugaLife Secures Rs 100 Crore to Revolutionize Wellness
HyugaLife Secures Rs 100 Crore to Revolutionize Wellness

HyugaLife raised Rs 100 crore in Series A funding to enhance AI-driven personalization and ensure product authenticity in the Indian supplement market....

Today

Read More
Full Text
GLP-1 Receptor Agonists in Psoriasis: A New Frontier for Dermatologists
GLP-1 Receptor Agonists in Psoriasis: A New Frontier for Dermatologists

New review explores GLP-1 receptor agonists as potential adjunctive treatments for psoriasis, targeting both skin lesions and metabolic comorbidities....

Today

Read More
Full Text
Optimizing Early Lactation: The Time-Specified Marmet Technique After Cesarean Section
Optimizing Early Lactation: The Time-Specified Marmet Technique After Cesarean Section

A randomized trial shows that a structured, time-specified Marmet technique significantly accelerates milk flow onset and increases volume in post-cesarean ...

Today

Read More
Full Text
Bridging the Diagnostic Gap: Timeliness of ATTR-CM Diagnosis in Heart Failure
Bridging the Diagnostic Gap: Timeliness of ATTR-CM Diagnosis in Heart Failure

A study of 7,770 Medicare patients reveals a median 494-day delay in ATTR-CM diagnosis after heart failure, highlighting critical gaps in clinical suspicion...

Today

Read More
Full Text
2026 ACE Clinical Guidelines for Knee Osteoarthritis Management
2026 ACE Clinical Guidelines for Knee Osteoarthritis Management

The 2026 ACE guidelines offer evidence-based recommendations for knee osteoarthritis, focusing on education, exercise, and holistic patient assessment....

Today

Read More
Full Text
Semaglutide and Motivation: New Insights into Reward Processing in MDD
Semaglutide and Motivation: New Insights into Reward Processing in MDD

A 16-week RCT found that 14 mg oral semaglutide significantly improves motivation in MDD patients by reducing effort discounting and the perceived cost of t...

Today

Read More
Full Text
Showing Page 1 of 1(5 items total)
Go to Page

"Wherever the art of Medicine is loved, there is also a love of Humanity."

— Hippocrates

made with❤️byOmnicuris